The beneficial effects of intra-gastric administration of apigenin to type 2 diabetic (T2D) rats were expressed as decreases of the blood glucose concentration and ICAM-1 levels and improved impaired glucose tolerance [189]. This evidence concerns the gene ICAM1 and type 2 diabetes mellitus.